Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
This product is intended solely for qualified researchers, laboratories, and institutions conducting in vitro or ex vivo scientific research
Drug interactions: Glutathione is theorized to reduce the cytotoxic efficacy of platinum-based chemotherapy agents (e.g., cisplatin) by binding reactive platinum species
N6-methyladenosine methyltransferase KIAA1429 promoted ovarian cancer aerobic glycolysis and progression through enhancing ENO1 expression
Glutathione S-transferase polymorphisms: susceptibility to migraine without aura [PMID: 12736537] Laboratory literature summary: Glutathione S-transferase polymorphisms: susceptibility to migraine without aura
Learn how your body responds, stabilize your dose, and establish a baseline before introducing AOD-9604
US$ 21.16
US$ 21.69
US$ 21.78
US$ 29.24
US$ 21.53
US$ 27.10
US$ 24.58
US$ 22.94
US$ 25.50
US$ 29.40
US$ 20.86
US$ 25.95
